|
October 2025 HOPE FOR HUNTINGTON’S: CLINICAL PERSPECTIVE ON THERAPEUTIC BREAKTHROUGHDanny Bega, MD, of Northwestern Medicine Neurology, joins Will Meador, MD, to discuss a major breakthrough in Huntington’s disease — a gene therapy that has shown the first evidence of slowing disease progression. Dr. Bega talks about how the RESET-HD trial is reshaping treatment possibilities and what physicians should watch for as this therapy advances.
|
Danny Bega, MD, Associate Professor of Movement Disorders at Northwestern Medicine
Refer a PatientNorthwestern Medicine welcomes the opportunity to partner with you in caring for your patients.
|
You May Also Like
|
|
|